Vinit Saxena is the founder and CEO of Sepragen Corporation, a company specializing in Bio-processing equipment and consumables for the production and purification of biological drugs and high-end nutritional ingredients. Sepragen's technology is covered by 16 patents and its products and technology are used globally by leading pharma companies such as Baxter, Amgen, GSK, Merck, Novartis and Sanofi Aventis as well several leading nutritional companies such as Fonterra, Mead Johnson and Carbery Food Ingredients. Sepragen’s products enable high throughput production at lower costs and their equipment has enabled Celltheon to expand its biomanufacturing capabilities. Mr. Saxena has over thirty (30) years of industry experience at companies at such as Bio-Rad Laboratories and Bio-Response (now Baxter Healthcare) before Sepragen. Mr Saxena is a graduate of IIT Kanpur, he has an MS in Chemical Engineering from Syracuse University and an MBA from U.C. Berkeley. He has authored 10 patents and is also the winner of several SBIR grants and the prestigious IR 100.